Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

212 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Drug therapy for coronary heart disease: the Sheffield table.
Ramsay LE, Wallis EJ, Haq IU, Yeo WW, Jackson PR. Ramsay LE, et al. Among authors: haq iu. Lancet. 1998 Feb 7;351(9100):443-4. doi: 10.1016/s0140-6736(98)26006-5. Lancet. 1998. PMID: 9482325 No abstract available.
Prediction of coronary risk for primary prevention of coronary heart disease: a comparison of methods.
Haq IU, Ramsay LE, Jackson PR, Wallis EJ. Haq IU, et al. QJM. 1999 Jul;92(7):379-85. doi: 10.1093/qjmed/92.7.379. QJM. 1999. PMID: 10627887
Targeting lipid-lowering drug therapy for primary prevention of coronary disease: an updated Sheffield table.
Ramsay LE, Haq IU, Jackson PR, Yeo WW, Pickin DM, Payne JN. Ramsay LE, et al. Among authors: haq iu. Lancet. 1996 Aug 10;348(9024):387-8. doi: 10.1016/s0140-6736(96)05516-x. Lancet. 1996. PMID: 8709740 No abstract available.
Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease.
Haq IU, Jackson PR, Yeo WW, Ramsay LE. Haq IU, et al. Lancet. 1995 Dec 2;346(8988):1467-71. doi: 10.1016/s0140-6736(95)92477-9. Lancet. 1995. PMID: 7490996
Use of statins. Sheffield table is useful.
Ramsay LE, Wallis EJ, Haq IU, Williamson R, Yeo WW, Jackson PR. Ramsay LE, et al. Among authors: haq iu. BMJ. 1998 Aug 15;317(7156):473-4. doi: 10.1136/bmj.317.7156.473a. BMJ. 1998. PMID: 9703541 Free PMC article. No abstract available.
Coronary risk assessment methods and cholesterol lowering.
Ramsay LE, Wallis EJ, Haq IU, Jackson PR. Ramsay LE, et al. Among authors: haq iu. Lancet. 1999 Mar 27;353(9158):1095; author reply 1096-7. doi: 10.1016/s0140-6736(99)00055-0. Lancet. 1999. PMID: 10199369 No abstract available.
The Sheffield table for primary prevention of coronary heart disease: corrected.
Ramsay LE, Haq IU, Jackson PR, Yeo WW. Ramsay LE, et al. Among authors: haq iu. Lancet. 1996 Nov 2;348(9036):1251. doi: 10.1016/s0140-6736(05)65536-5. Lancet. 1996. PMID: 8898071 No abstract available.
Cholesterol and prevention of coronary heart disease.
Haq IU, Jackson PR, Yeo WW, Ramsay LE. Haq IU, et al. Lancet. 1997 Jan 18;349(9046):210-1. doi: 10.1016/s0140-6736(05)60956-7. Lancet. 1997. PMID: 9111570 No abstract available.
Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention Study.
Haq IU, Wallis EJ, Yeo WW, Jackson PR, Ramsay LE. Haq IU, et al. JAMA. 1999 Feb 3;281(5):414; author reply 417-9. JAMA. 1999. PMID: 9952191 No abstract available.
Cost effectiveness of HMG-CoA reductase inhibitor (statin) treatment related to the risk of coronary heart disease and cost of drug treatment.
Pickin DM, McCabe CJ, Ramsay LE, Payne N, Haq IU, Yeo WW, Jackson PR. Pickin DM, et al. Among authors: haq iu. Heart. 1999 Sep;82(3):325-32. doi: 10.1136/hrt.82.3.325. Heart. 1999. PMID: 10455083 Free PMC article.
212 results
Jump to page
Feedback